Home
Scholarly Works
Patient eligibility and trial design for the...
Conference

Patient eligibility and trial design for the salvage therapy of advanced urothelial carcinoma (UC) based on the impact of prognostic factors.

Authors

Sonpavde G; Bellmunt J; Rosenberg JE; Bajorin DF; Regazzi AM; Choueiri TK; Qu AQ; Niegisch G; Albers P; Necchi A

Volume

32

Pagination

pp. 4514-4514

Publisher

American Society of Clinical Oncology (ASCO)

Publication Date

May 20, 2014

DOI

10.1200/jco.2014.32.15_suppl.4514

Conference proceedings

Journal of Clinical Oncology

Issue

15_suppl

ISSN

0732-183X
View published work (Non-McMaster Users)

Contact the Experts team